단일염기다형성(SNP) 지노타이핑 시장 규모, 점유율 및 성장 분석 : 제품 유형별, 기술 플랫폼별, 검체 매트릭스별, 애플리케이션 벡터별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global Single Nucleotide Polymorphism (SNP) Genotyping Market size was valued at USD 36.64 Billion in 2024 and is poised to grow from USD 44.74 Billion in 2025 to USD 221.00 Billion by 2033, growing at a CAGR of 22.1% during the forecast period (2026-2033).

The global single nucleotide polymorphism (SNP) genotyping market is experiencing significant growth driven by advanced technologies that identify single-base DNA changes, which play a crucial role in personalized healthcare, agricultural enhancements, and forensic applications. This capacity links genetic markers to critical outcomes such as disease predisposition and treatment responses, thereby shaping clinical and agricultural strategies. The evolution of SNP genotyping methods-from early PCR approaches to cutting-edge next-generation sequencing and CRISPR-inspired techniques-illustrates the dynamic nature of this market. Increasing demands for precision therapeutic solutions and biomarker-driven drug development are propelling investments in high-throughput, affordable platforms. This trend has led to the emergence of scalable SNP panels, reducing sample costs significantly and promoting rapid agricultural advancements through efficient germplasm screening.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Single Nucleotide Polymorphism (SNP) Genotyping market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Single Nucleotide Polymorphism (SNP) Genotyping Market Segments Analysis

Global single nucleotide polymorphism (SNP) genotyping market is segmented by product offering type, technology platform, sample specimen matrix, application vector, end user focus and region. Based on product offering type, the market is segmented into consumables, instruments, software and services. Based on technology platform, the market is segmented into polymerase chain reaction, next generation sequencing, microarrays, geneChips, TaqMan allelic discrimination, single nucleotide polymorphism pyrosequencing, SNPlex genotyping systems and Sequenom MassARRAY matrix-assisted laser desorption/ionization time-of-flight. Based on sample specimen matrix, the market is segmented into blood specimen, saliva swabs, buccal cells, plant tissue samples and animal tissue samples. Based on application vector, the market is segmented into diagnostic research, forensics testing, pharmacogenomics analysis, agricultural biotechnology, crop breeding programs and animal livestock optimization. Based on end user focus, the market is segmented into academic research institutes, pharmaceutical corporations, biotechnology establishments, diagnostic laboratories, forensic crime laboratories and agrigenomics centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Single Nucleotide Polymorphism (SNP) Genotyping Market

The growing focus on personalized medicine significantly boosts the demand for Single Nucleotide Polymorphism (SNP) genotyping, as healthcare providers recognize the necessity of detailed genetic variation information for effective drug selection and dosage optimization. By identifying specific single nucleotide variations, clinicians can anticipate patient responses to therapies, minimize adverse effects, and enhance overall treatment results. This importance of SNP testing prompts healthcare professionals to adopt it into standard diagnostic practices, leading laboratories to broaden their services and prompting technology developers to upgrade assay sensitivity and throughput, thus driving substantial growth within the global healthcare landscape.

Restraints in the Global Single Nucleotide Polymorphism (SNP) Genotyping Market

The Global Single Nucleotide Polymorphism (SNP) Genotyping market faces significant challenges due to the high costs associated with genotyping platforms. This financial barrier impedes widespread adoption, especially in resource-limited healthcare environments where funding often prioritizes essential services over advanced diagnostic tools. The considerable initial investment needed for equipment, consumables, and trained personnel limits access for smaller laboratories and emerging markets. As a result, many institutions may delay the incorporation of SNP genotyping into routine procedures, favoring more affordable alternatives, which hinders market penetration and growth potential. Additionally, ongoing expenses related to maintenance and software updates pose further challenges, dissuading long-term adoption by budget-conscious organizations.

Market Trends of the Global Single Nucleotide Polymorphism (SNP) Genotyping Market

The Global Single Nucleotide Polymorphism (SNP) Genotyping market is witnessing a transformative trend, characterized by the integration of SNP analysis into precision medicine approaches. As healthcare providers prioritize personalized treatment plans, the reliance on genotype-driven risk assessments is elevating the collaboration between diagnostic firms and pharmaceutical companies. This shift is leading to an increased demand for comprehensive, high-throughput SNP panels that are clinically validated. Vendors are responding by developing integrated data platforms that link genetic insights with electronic health records, enhancing accessibility and utility in diverse patient populations and expanding into new therapeutic domains.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Product Offering Type & CAGR (2026-2033)

• Market Overview
• Consumables
  • Reagents
  • Assay Kits
  • Genotyping Chips
• Instruments
  • Sequencers
  • Mass Spectrometers
  • Microarray Scanners
• Software
• Services
  • Professional Services
  • Managed Services

Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Technology Platform & CAGR (2026-2033)

• Market Overview
• Polymerase Chain Reaction
• Next Generation Sequencing
• Microarrays
• GeneChips
• Taqman Allelic Discrimination
• Single Nucleotide Polymorphism Pyrosequencing
• SNPlex Genotyping Systems
• Sequenom MassARRAY Matrix-Assisted Laser Desorption/Ionization Time-of-Flight

Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Sample Specimen Matrix & CAGR (2026-2033)

• Market Overview
• Blood Specimen
• Saliva Swabs
• Buccal Cells
• Plant Tissue Samples
• Animal Tissue Samples

Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by Application Vector & CAGR (2026-2033)

• Market Overview
• Diagnostic Research
• Forensics Testing
• Pharmacogenomics Analysis
• Agricultural Biotechnology
• Crop Breeding Programs
• Animal Livestock Optimization

Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size by End User Focus & CAGR (2026-2033)

• Market Overview
• Academic Research Institutes
• Pharmaceutical Corporations
• Biotechnology Establishments
• Diagnostic Laboratories
• Forensic Crime Laboratories
• Agrigenomics Centers

Global Single Nucleotide Polymorphism (SNP) Genotyping Market Size & CAGR (2026-2033)

• North America (Product Offering Type, Technology Platform, Sample Specimen Matrix, Application Vector, End User Focus)
  • US
  • Canada
• Europe (Product Offering Type, Technology Platform, Sample Specimen Matrix, Application Vector, End User Focus)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Offering Type, Technology Platform, Sample Specimen Matrix, Application Vector, End User Focus)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Offering Type, Technology Platform, Sample Specimen Matrix, Application Vector, End User Focus)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Offering Type, Technology Platform, Sample Specimen Matrix, Application Vector, End User Focus)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Illumina Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Standard BioTools Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LGC Biosearch Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GenScript Biotech Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• New England Biolabs Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Promega Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integrated DNA Technologies Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macrogen Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ArrayGen Technologies Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novogene Co. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genos
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations